Showing posts with label Health & wellness. Show all posts
Showing posts with label Health & wellness. Show all posts

Saturday, 12 July 2014

HEALTH & WELLNESS: To cure obesity, we need therapies that address overeating’s link to depression, mood disorders

To cure obesity, we need therapies that address overeating’s link to depression, mood disorders

http://news.nationalpost.com/2014/07/07/to-cure-obesity-we-need-therapies-that-address-overeatings-link-to-depression-mood-disorders/
 |  | Last Updated:Jul 7 6:22 PM E
T
Obesity is a persistent problem that kills many people every year and which we don't entirely understand, Dr. David Macklin, an expert on the disease, writes.
Kirsty Wigglesworth/AP filesObesity is a persistent problem that kills many people every year and which we don't entirely understand, Dr. David Macklin, an expert on the disease, writes.

As a family physician whose practice deals exclusively in the treatment of obesity, it strikes me as remarkable how little we understand the disease, which is Canada’s second-leading cause of preventable death.
Recently, though, the fight against obesity is showing signs of joining the 21st century. For example, this autumn many in the medical profession expect the Food and Drug Administration in the United States to approve what I believe will be a really promising pharmaceutical therapy for obesity.In every region of the developed world, rates of obesity doubled in the 20 years between 1988 and 2008, according to World Health Organization, which now counts more than a half-billion of Earth’s population as obese. The Public Health Agency of Canada says obesity costs our country somewhere between $4.6-billion to $7.1-billion every year. Even with these stark facts, the most effective long-term therapy we’ve come up with to treat the disease is bariatric surgery — a comparatively radical procedure that sees a surgeon restrict the size of the stomach, or cut off a piece of it.
The drug’s development stems from an evolving understanding of a certain type of overeating that arises from stress-triggered depression. The path to obesity may begin for some people with a stressful event that the person perceives as threatening — ranging from early life abuse to the loss of a job or a loved one. The resulting release of stress hormones interferes with the brain’s stimulus-reward circuitry. Essentially, the stress takes away one’s ability to feel pleasure. The resulting condition is referred to as “anhedonia,” and it’s one of the two primary symptoms of depression.  
The next step sees some anhedonia sufferers go off in search of other ways to activate their reward circuitry and feel pleasure. Most of the options remaining to them are unhealthy. Drugs and alcohol will get the job done, as can three substances that are far less regulated than intoxicants — sugar, salt and fat.
With few other options available to feel pleasure, the anhedonic person turns to the consumption of calorie-dense foods to fire their pleasure receptors. And over time, conditioning leads to a powerful drive to overeat — with stress and common settings such as a couch and a TV triggering an overwhelming impulse to consume.
We live in a stressful world where we have virtually unlimited access to sugar, fat and salt — foods laden with them are available at any time of day, nearly anywhere, and are often super-sized and inexpensive. Throw stress at us and studies show that while 30% of us will lose weight, the remaining 70% of us will eat more and gain weight. And interestingly, 70% of Canadians are obese or overweight.
I have spent more than 12,000 hours treating obesity in the last 10 years and it is becoming increasingly apparent to me that this stress-anhedonia-overeating pathology may be contributing to the struggles of a majority of my patients.
Understanding that a link exists between stress, depression and obesity is allowing the pharmaceutical industry to tailor treatments to address the connections and the pathway that makes them possible. For example, a California-based company called Orexigen Therapeutics is in the final stages of seeking FDA approval for a drug it’s marketing under the name of Contrave. The pharmaceutical therapy actually is a combination of two drugs — an anti-depressant, buproprion, and naltrexone, an anti-addiction drug currently used to treat people for alcohol dependence. The buproprion alleviates the anhedonia that triggers the overeating, and in clinical trials, Contrave, combined with behavioural modification treatment, helped subjects lose an average of 10% of their body weight. And 10% weight loss is sufficient to treat early-stage diabetes. It’s expected to be approved by the FDA this fall, suggesting the possibility of a similar decision down the road by Health Canada. And other pharmaceutical therapies that combine anti-depressants with other drugs also are in the pipeline.
More exciting than any single drug, though, is the fact that the medical profession is developing new and more sophisticated ways to manage overeating itself. Will the new understanding stem the rise of obesity-related deaths? Could treatments based on our new understandings of why many overeat help you, or someone you know, address a developing weight problem? The only certainty is that the medical profession needs more tools, in addition to surgery, to address the growing obesity epidemic — and with new behavioural and pharmaceutical treatments we are getting them.
—Dr. David Macklin directs the weight management program at the Medcan Clinic, a leading preventive health clinic in Toronto. Dr. James Aw is on sabbatical. For more information, visit medcan.com.

Wednesday, 11 June 2014

HEALTH & WELLNESS: Saturated Fat Triggers Genetic Predisposition to Obesity


Saturated Fat Triggers Genetic Predisposition to Obesity
 - Blogs
Print

Limiting saturated fat could help people whose genetic make-up increases their chance of being obese.

In a new study, researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging (USDA HNRCA) at Tufts University identified 63 gene variants related to obesity and used them to calculate a genetic risk score for obesity for more than 2,800 white, American men and women enrolled in two large studies on heart disease prevention. People with a higher genetic risk score, who also consumed more of their calories as saturated fat, were more likely to have a higher body mass index (BMI).

This isn’t the first time a saturated-fat consumption has been associated with health risks. In fact, the health perils of a diet high in saturated fats is well documented. The 2010 U.S. Dietary Guidelines for Americans recommends consuming less than 10 percent of calories as saturated fats. To read more, download the free Digital Issue, “Survival Guide: Fats & Oils."

"We already know there are certain genes that interact with dietary fat and affect BMI," said senior author José M. Ordovás, Ph.D., director of the Nutrition and Genomics Laboratory, USDA HNRCA, and professor, Friedman School of Nutrition Science and Policy, Tufts University. "In the current study, we analyzed dozens of variants of those genes and other genes frequently associated with obesity risk and saw that, while total fat intake was related to higher BMI, people who were genetically predisposed to obesity and ate the most saturated fat had the highest BMIs."

The findings, which account for possible confounding factors such as age, sex, and physical activity levels, are published online ahead of print in the Journal of the Academy of Nutrition and Dietetics.

Ordovás and colleagues hypothesize that people who have these gene variants that predispose them to obesity may be more sensitive to saturated fat, which is found mostly in fatty cuts of meats, including beef and pork, as well as butter, cheese and other high-fat dairy products.

"Little is known about the mechanisms that might explain the role of saturated fat intake in obesity," said Ordovás. "Some clinical models suggest that saturated fat might interfere with activity in the part of the brain that lets us know we're full, in addition to a few studies in people that suggest a diet high in saturated fat interferes with satiety. More research is needed to know whether those findings would also apply to gene function."

Genetic risk score could be useful in identifying people who are predisposed to obesity and could ultimately lead to personalized dietary recommendations. "If further research can clarify a relationship between obesity related genes and saturated fat, people with higher scores would have even more incentive to follow advice to limit their saturated fat intake as part of an obesity prevention strategy," Ordovás said.

Ingredient innovation is helping food product designers to create products with reduced saturated-fat content while maintaining quality. According to Dilip Nakhasi, director of innovation, Bunge North America, new technology can create saturate-sparing fats that have less saturates and virtually no trans fatty acids while maintaining functionality of typical shortening systems. The technology combines two components—the manipulation of fatty acids and added fiber ingredients. For a closer look, watch the FoodTech Toolbox video, “Saturate-Sparing Fats."